South African study using J&J vaccine will resume
SOUTH African researchers will tomorrow resume a study further evaluating the efficacy of Johnson & Johnson's COVID-19 vaccine in the field, after it was temporarily suspended along with use of the shot in the United States. U.S. regulators recommended pausing the use of the single-shot earlier this month due to extremely rare cases of blood clots but on Friday said the United States could restart vaccinations. Europe's drug regulator has backed its overall benefits against any risk. The Sisonke study is being carried out by the National Department of Health, South African Medical Research Council and Johnson & Johnson among…